Effect of mitochondrial complex I inhibition on Fe-S cluster protein activity

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 241-246

  Mena, Natalia P ^a,b   Bulteau, Anne Laure ^c,d   Salazar, Julio ^b   Hirsch, Etienne C ^c,d   Núñez, Marco T ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b Centre for Biochemical Engineering and Biotechnology   (Chile)

^c SORBONNE UNIVERSITÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Iron metabolism; Iron sulfur clusters; IRP1; Mitochondrial complex I inhibition

Indexed keywords

AMIDOPHOSPHORIBOSYLTRANSFERASE; GLUTAMINE PHOSPHORIBOSYL PYROPHOSPHATE AMIDOTRANSFERASE; IRON REGULATORY FACTOR; IRON SULFUR PROTEIN; MITOCHONDRIAL ACONITASE; MITOCHONDRIAL ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IRON DEFICIENCY; MITOCHONDRION; NEUROBLASTOMA CELL; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ACONITATE HYDRATASE; CELL LINE, TUMOR; CYTOSOL; ELECTRON TRANSPORT COMPLEX I; HUMANS; IRON REGULATORY PROTEIN 1; IRON-SULFUR PROTEINS; MITOCHONDRIA; ROTENONE;

EID: 79957921030     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.137     Document Type: Article

References (37)

1. Bandyopadhyay S., Chandramouli K., Johnson M.K. Iron-sulfur cluster biosynthesis. Biochem. Soc. Trans. 2008, 36:1112-1119.
2. Rouault T.A., Tong W.H. Iron-sulfur cluster biogenesis and human disease. Trends Genet. 2008, 24:398-407.
3. Lill R., Muhlenhoff U. Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu. Rev. Biochem. 2008, 77:669-700.
4. Martelli A., Wattenhofer-Donze M., Schmucker S., Bouvet S., Reutenauer L., Puccio H. Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues. Hum. Mol. Genet. 2007, 16:2651-2658.
5. Rouault T.A., Tong W.H. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat. Rev. Mol. Cell Biol. 2005, 6:345-351.
6. Sheftel A., Stehling O., Lill R. Iron-sulfur proteins in health and disease. Trends Endocrinol. Metab. 2010, 21:302-314.
7. Richardson D.R., Lane D.J., Becker E.M., Huang M.L., Whitnall M., Rahmanto Y.S., Sheftel A.D., Ponka P. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc. Natl. Acad. Sci. USA 2010, 107:10775-10782.
8. Cammack R. Iron-sulphur cluster interconversions and the activation of aconitase. Nature 1982, 298:792-793.
9. Nishino T., Okamoto K. The role of the [2Fe-2S] cluster centers in xanthine oxidoreductase. J. Inorg. Biochem. 2000, 82:43-49.
10. Makaroff C.A., Paluh J.L., Zalkin H. Mutagenesis of ligands to the [4Fe-4S] center of Bacillus subtilis glutamine phosphoribosyl pyrophosphate amidotransferase. J. Biol. Chem. 1986, 261:11416-11423.
11. Lill R., Muhlenhoff U. Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms. Annu. Rev. Cell Dev. Biol. 2006, 22:457-486.
12. Lill R., Dutkiewicz R., Elsasser H.P., Hausmann A., Netz D.J., Pierik A.J., Stehling O., Urzica E., Muhlenhoff U. Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol, and nucleus of eukaryotes. Biochim. Biophys. Acta 2006, 1763:652-667.
13. Linton K.J., Higgins C.F. Structure and function of ABC transporters: the ATP switch provides flexible control. Pflugers Arch. 2007, 453:555-567.
14. Muhlenhoff U., Richhardt N., Gerber J., Lill R. Characterization of iron-sulfur protein assembly in isolated mitochondria. A requirement for ATP, NADH, and reduced iron. J. Biol. Chem. 2002, 277:29810-29816.
15. Kubo Y., Tsunehiro T., Nishikawa S., Nakai M., Ikeda E., Toh-e A., Morishima N., Shibata T., Endo T. Two distinct mechanisms operate in the reactivation of heat-denatured proteins by the mitochondrial Hsp70/Mdj1p/Yge1p chaperone system. J. Mol. Biol. 1999, 286:447-464.
16. Dutkiewicz R., Schilke B., Knieszner H., Walter W., Craig E.A., Marszalek J. Ssq1, a mitochondrial Hsp70 involved in iron-sulfur (Fe/S) center biogenesis. Similarities to and differences from its bacterial counterpart. J. Biol. Chem. 2003, 278:29719-29727.
17. Sipos K., Lange H., Fekete Z., Ullmann P., Lill R., Kispal G. Maturation of cytosolic iron-sulfur proteins requires glutathione. J. Biol. Chem. 2002, 277:26944-26949.
18. Lee D.W., Kaur D., Chinta S.J., Rajagopalan S., Andersen J.K. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease. Antioxid. Redox Signal. 2009, 11:2083-2094.
19. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
20. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 2003, 23:10756-10764.
21. Pahlman S., Ruusala A.I., Abrahamsson L., Mattsson M.E., Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell. Differ. 1984, 14:135-144.
22. Presgraves S.P., Ahmed T., Borwege S., Joyce J.N. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox. Res. 2004, 5:579-598.
23. Bulteau A.L., Ikeda-Saito M., Szweda L.I. Redox-dependent modulation of aconitase activity in intact mitochondria. Biochemistry 2003, 42:14846-14855.
24. Janssen A.J., Trijbels F.J., Sengers R.C., Smeitink J.A., van den Heuvel L.P., Wintjes L.T., Stoltenborg-Hogenkamp B.J., Rodenburg R.J. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin. Chem. 2007, 53:729-734.
25. Leibold E.A., Munro H.N. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl. Acad. Sci. USA 1988, 85:2171-2175.
26. Epsztejn S., Kakhlon O., Glickstein H., Breuer W., Cabantchik I. Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 1997, 248:31-40.
27. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat. Res. 2003, 531:81-92.
28. Barrientos A., Moraes C.T. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 1999, 274:16188-16197.
29. Paraskeva E., Hentze M.W. Iron-sulphur clusters as genetic regulatory switches: the bifunctional iron regulatory protein-1. FEBS Lett. 1996, 389:40-43.
30. Bulteau A.L., Lundberg K.C., Ikeda-Saito M., Isaya G., Szweda L.I. Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion. Proc. Natl. Acad. Sci. USA 2005, 102:5987-5991.
31. Bulteau A.L., Szweda L.I., Friguet B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp. Gerontol. 2006, 41:653-657.
32. Meneshian A., Bulkley G.B. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 2002, 9:161-175.
33. Muckenthaler M.U., Galy B., Hentze M.W. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 2008, 28:197-213.
34. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., Marsden C.D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 1989, 52:1830-1836.
35. Jellinger K., Paulus W., Grundke-Iqbal I., Riederer P., Youdim M.B. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Transm. Park Dis. Dement. Sect. 1990, 2:327-340.
36. Hirsch E.C., Brandel J.P., Galle P., Javoy-Agid F., Agid Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 1991, 56:446-451.
37. Schapira A.H., Mann V.M., Cooper J.M., Dexter D., Daniel S.E., Jenner P., Clark J.B., Marsden C.D. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 1990, 55:2142-2145.